Luke Evnin
Director, Genome Therapeutics Corporation.
Companies
- Werewolf Therapeutics, Inc.Board member Apr 29, 2021 to now1
- Oncorus, Inc.Board member Oct 1, 2020 to Jun 24, 20222
- TURMERIC ACQUISITION CORP.Chief executive officer Oct 15, 2020 to Apr 30, 20213
- Harpoon Therapeutics, Inc.Board member Feb 7, 2019 to Jun 1, 20204
- Syndax Pharmaceuticals IncBoard member Mar 2, 2016 to May 25, 20185
- Pacira BioSciences, Inc.Board member Feb 2, 2011 to Jun 13, 20136
- Genome Therapeutics CorporationBoard member Jan 4, 2006 to Jan 9, 20067
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Werewolf Therapeutics, Inc. HOWL0 shares8Jul 7, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 7, 2026Sold 107,429 shares at $0.31 of Werewolf Therapeutics, Inc.8
- Jul 6, 2026Sold 35,770 shares at $0.32 of Werewolf Therapeutics, Inc.8
- Jun 29, 2026Sold 157,084 shares at $0.30 of Werewolf Therapeutics, Inc.9
- Jun 9, 2026Sold 76,928 shares at $0.37 of Werewolf Therapeutics, Inc.10
- Jun 8, 2026Sold 60,547 shares at $0.40 of Werewolf Therapeutics, Inc.11
- Jun 5, 2026Sold 24,946 shares at $0.40 of Werewolf Therapeutics, Inc.11
- Jun 4, 2026Sold 20,072 shares at $0.44 of Werewolf Therapeutics, Inc.11
- Jun 3, 2026Sold 29,749 shares at $0.42 of Werewolf Therapeutics, Inc.12
- Jun 2, 2026Sold 29,595 shares at $0.45 of Werewolf Therapeutics, Inc.12
- Jun 1, 2026Sold 80,459 shares at $0.47 of Werewolf Therapeutics, Inc.12
- May 29, 2026Sold 32,556 shares at $0.45 of Werewolf Therapeutics, Inc.13
- May 28, 2026Sold 27,698 shares at $0.46 of Werewolf Therapeutics, Inc.13
- May 27, 2026Sold 80,852 shares at $0.48 of Werewolf Therapeutics, Inc.13
- May 26, 2026Sold 67,950 shares at $0.47 of Werewolf Therapeutics, Inc.14
- May 22, 2026Sold 87,425 shares at $0.45 of Werewolf Therapeutics, Inc.14
- May 21, 2026Sold 36,387 shares at $0.42 of Werewolf Therapeutics, Inc.14
- May 20, 2026Sold 85,895 shares at $0.43 of Werewolf Therapeutics, Inc.15
- May 19, 2026Sold 62,970 shares at $0.45 of Werewolf Therapeutics, Inc.15
- May 18, 2026Sold 22,184 shares at $0.50 of Werewolf Therapeutics, Inc.15
- May 13, 2026Sold 44,679 shares at $0.54 of Werewolf Therapeutics, Inc.16
- May 12, 2026Sold 67,885 shares at $0.64 of Werewolf Therapeutics, Inc.17
- May 11, 2026Sold 33,948 shares at $0.67 of Werewolf Therapeutics, Inc.17
- May 8, 2026Sold 305,741 shares at $0.70 of Werewolf Therapeutics, Inc.17
- May 7, 2026Sold 79,086 shares at $0.63 of Werewolf Therapeutics, Inc.18
- May 6, 2026Sold 14,635 shares at $0.66 of Werewolf Therapeutics, Inc.18
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGAROncorus, Inc., Board member
- 3
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Jun 29, 2026
- 10SEC EDGARForm 4 filed Jun 10, 2026
- 11SEC EDGARForm 4 filed Jun 8, 2026
- 12SEC EDGARForm 4 filed Jun 3, 2026
- 13SEC EDGARForm 4 filed May 29, 2026
- 14SEC EDGARForm 4 filed May 26, 2026
- 15SEC EDGARForm 4 filed May 20, 2026
- 16SEC EDGARForm 4 filed May 13, 2026
- 17SEC EDGARForm 4 filed May 12, 2026
- 18SEC EDGARForm 4 filed May 7, 2026